We go through four case studies looking through the different stages of the product life cycle:
- How CLIENT 1, an ex-US, ex-EU biotech company, found that opportunities for its technology were more dependent on the patient types and partnered with another company to achieve series A funding (being valued at $500 million) within the year.
- How CLIENT 2, a large biotech company, conducted a deep-dive on its competitors’ drug developments, improved cross-functional alignment within the company and used its window of exclusivity for a new drug to achieve above-forecast revenues.
- How CLIENT 3, a small biotech company, discovered the value of building patient support programs, enabling the company to punch above its weight with its rare disease product.
- How CLIENT 4, a large biotech company, came from a starting position of zero market research to create potential future scenarios to plan post-launch strategies and achieved revenues approximately 70% higher than forecast.
Download the white paper now to examine the strategies that four clients used to achieve beneficial outcomes in demonstrating the importance of developing value-based insights.